Search Results - "GARNER, R. C"

Refine Results
  1. 1

    Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing by Combes, R.D, Berridge, T, Connelly, J, Eve, M.D, Garner, R.C, Toon, S, Wilcox, P

    “…Testing the safety and efficacy of a successful human medicine involves many laboratory animals, which can sometimes be subjected to considerable suffering and…”
    Get full text
    Journal Article
  2. 2

    Pediatric microdose and microtracer studies using 14C in Europe by Turner, MA, Mooij, MG, Vaes, WHJ, Windhorst, AD, Hendrikse, NH, Knibbe, CAJ, Kõrgvee, LT, Maruszak, W, Grynkiewicz, G, Garner, RC, Tibboel, D, Park, BK, de Wildt, SN

    Published in Clinical pharmacology and therapeutics (01-09-2015)
    “…Important information gaps remain on the efficacy and safety of drugs in children. Pediatric drug development encounters several ethical, practical, and…”
    Get full text
    Journal Article
  3. 3

    Accelerator Mass Spectrometry Measurement of Intracellular Concentrations of Active Drug Metabolites in Human Target Cells In Vivo by Chen, J, Garner, R C, Lee, L S, Seymour, M, Fuchs, E J, Hubbard, W C, Parsons, T L, Pakes, G E, Fletcher, C V, Flexner, C

    Published in Clinical pharmacology and therapeutics (01-12-2010)
    “…Accelerator mass spectrometry (AMS) is an ultrasensitive technique to detect radiolabeled compounds. We administered a microdose (100 µg) of 14C‐labeled…”
    Get full text
    Journal Article
  4. 4

    Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry by Beumer, J H, Garner, R C, Cohen, M B, Galbraith, S, Duncan, G F, Griffin, T, Beijnen, J H, Schellens, J H M

    Published in Investigational new drugs (01-08-2007)
    “…Ixabepilone (BMS-247550) is a semi-synthetic, microtubule stabilizing epothilone B analogue which is more potent than taxanes and has displayed activity in…”
    Get full text
    Journal Article
  5. 5

    Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom by Barker, J., Garner, R. C.

    Published in Rapid communications in mass spectrometry (28-02-1999)
    “…Accelerator mass spectrometry (AMS) is a nuclear physics technique developed about twenty years ago, that uses the high energy (several MeV) of a tandem Van de…”
    Get full text
    Journal Article
  6. 6

    Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein by Lappin, G., Garner, R.C., Meyers, T., Powell, J., Varley, P.

    “…Although 14C-labelling has been routinely used for small molecules, this technique is not routinely applied to therapeutic proteins due to difficulties of…”
    Get full text
    Journal Article
  7. 7

    Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer by Barrett, J.H., Smith, G., Waxman, R., Gooderham, N., Lightfoot, T., Garner, R.C., Augustsson, K., Wolf, C.R., Bishop, D.T., Forman, D.

    Published in Carcinogenesis (New York) (01-02-2003)
    “…Fast N-acetyltransferase 2 (NAT2) acetylators may be at increased risk of colorectal cancer through the activation of carcinogenic heterocyclic amines (HA),…”
    Get full text
    Journal Article
  8. 8

    Determination of the Bioavailability of [14C]-Hexaminolevulinate Using Accelerator Mass Spectrometry After Intravesical Administration to Human Volunteers by Klem, B., Lappin, G., Nicholson, S., van de Wetering, J., de Vries, D. E., Oosterhuis, B., Garner, R. C.

    Published in Journal of clinical pharmacology (01-04-2006)
    “…Hexaminolevulinate (HAL) is a diagnostic agent that allows the visualization of tumor tissue in the bladder by fluorescence cystoscopy. It is administered…”
    Get full text
    Journal Article
  9. 9

    Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement by Garner, R C

    Published in Current drug metabolism (01-09-2000)
    “…Accelerator mass spectrometry (AMS) permits the measurement of elemental isotopes at the individual atom level. The main application of AMS in drug discovery…”
    Get more information
    Journal Article
  10. 10

    Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine and benzo[a]pyrene by Lightfoot, T.J, Coxhead, J.M, Cupid, B.C, Nicholson, S, Garner, R.C

    Published in Mutation research (20-12-2000)
    “…Epidemiological evidence has suggested an association between meat consumption and the risk of breast cancer. 2-Amino-1-methyl-6-phenylimidazo[4,5- b]pyridine…”
    Get full text
    Journal Article
  11. 11

    Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses by Turteltaub, Kenneth W, Dingley, Karen H, Curtis, Kellie D, Malfatti, Michael A, Turesky, Robert J, Colin Garner, R, Felton, James S, Lang, Nicholas P

    Published in Cancer letters (01-09-1999)
    “…2-Amino-3,8-dimethylimidazo[4,5- f]quinoxaline (MeIQx) and 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) are heterocyclic amines formed during the…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Comparative biotransformation studies of MeIQx and PhIP in animal models and humans by Garner, R.C, Lightfoot, T.J, Cupid, B.C, Russell, D, Coxhead, J.M, Kutschera, W, Priller, A, Rom, W, Steier, P, Alexander, D.J, Leveson, S.H, Dingley, K.H, Mauthe, R.J, Turteltaub, K.W

    Published in Cancer letters (01-09-1999)
    “…MeIQx and PhIP are putative carcinogenic heterocyclic amines formed during the cooking of meat and fish. Using accelerator mass spectrometry, we have…”
    Get full text
    Journal Article Conference Proceeding
  13. 13

    Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers by XU, X, STOWER, M. J, REID, I. N, GARNER, R. C, BURNS, P. A

    Published in Clinical cancer research (01-10-1996)
    “…Thirteen of 28 patients (46%) with grade 2-3 multifocal transitional cell carcinoma (TCC) of the bladder were found to have p53 mutations using DNA sequence…”
    Get full text
    Journal Article
  14. 14

    O20 Dose-linearity of the pharmacokinetics of an intravenous [14C]midazolam microdose in children by van Groen, BD, Vaes, WHJ, Park, BK, Krekels, EHJ, van Duijn, E, Kõrgvee, L-T, Maruszak, W, Grynkiewicz, G, Garner, RC, Knibbe, C, Tibboel, D, de Wildt, SN, Turner, MA

    Published in Archives of disease in childhood (01-06-2019)
    “…BackgroundDrug disposition in children may vary from adults due to age-related variation in drug metabolism, but paediatric pharmacokinetic (PK) studies are…”
    Get full text
    Journal Article
  15. 15

    Mutations in APC, Kirsten-Ras, and p53-Alternative Genetic Pathways to Colorectal Cancer by Smith, Gillian, Carey, Francis A., Beattie, Julie, Murray J. V. Wilkie, Lightfoot, Tracy J., Coxhead, Jonathan, Garner, R. Colin, Robert J. C. Steele, Wolf, C. Roland

    “…Colorectal cancer is one of the most significant causes of cancer death. A genetic model for colorectal cancer has been proposed in which the sequential…”
    Get full text
    Journal Article
  16. 16

    Smoking-related DNA adducts in human gastric cancers by Dyke, G W, Craven, J L, Hall, R, Garner, R C

    Published in International journal of cancer (02-12-1992)
    “…DNA was extracted from the tumour tissue of 26 patients (18 smokers, 8 non-smokers) undergoing surgery for gastric cancer, and analyzed for the presence of DNA…”
    Get more information
    Journal Article
  17. 17

    Correlation of DNA adduct levels in human lung with cigarette smoking by Phillips, David H, Hewer, Alan, Martin, Carl N, Garner, R. Colin, King, Maureen M

    Published in Nature (London) (22-12-1988)
    “…Lung cancer is the most common cancer in men in the United Kingdom and the second most common in women, accounting for between 25 and 40% of all cancer deaths…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses : Comparison of human subjects and F344 rats by DINGLEY, K. H, FREEMAN, S. P. H. T, NELSON, D. O, GARNER, R. C, TURTELTAUB, K. W

    Published in Drug metabolism and disposition (01-08-1998)
    “…Covalent binding of the food-borne heterocyclic amine 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) to albumin and hemoglobin (Hb), 3.5-6.0 hr after…”
    Get full text
    Journal Article
  20. 20

    Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting by Garner, R C, Garner, J V, Gregory, S, Whattam, M, Calam, A, Leong, D

    Published in Journal of pharmaceutical sciences (01-01-2002)
    “…Daflon 500 mg, is a micronized purified flavonoid fraction, containing 90% w/w diosmin and 10% w/w of flavonoids expressed as hesperidin, used clinically in…”
    Get more information
    Journal Article